COMP <GO>
SAIA vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Saia Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: SAIA 4
— TMO 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMO
LAST: $344.61 (+0.45%) • MKT CAP: $9.15B
roic
8.50%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SAIA VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SAIA | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 8.50% | 9.30% | -0.80 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.8x | 30.4x | -18.60 | SAIA | /valuation <GO> |
| Free Cash Flow Yield | 0.30% | 2.40% | -2.10 | TMO | /fcf-yield <GO> |
| Operating Margin | 10.90% | 17.40% | -6.50 | TMO | /operating-margins <GO> |
| Net Profit Margin | 7.90% | 15.10% | -7.20 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 0.80% | 3.90% | -3.10 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.52 | 4.50 | +1.02 | SAIA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.70% | +0.60 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.8 | 59.1 | -6.32 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.12 | 0.94 | +0.18 | SAIA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.4x | 36.3x | -2.90 | SAIA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.15B | $262.22B | -$253.07B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SAIA REV | TMO REV | SAIA GROSS % | TMO GROSS % | SAIA FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.23B | $44.56B | 44.0% | 44.0% | $27.3M | $6.29B |
| FY 2024 | $3.21B | $42.88B | 44.0% | 44.0% | -$459.9M | $7.27B |
| FY 2023 | $2.88B | $42.86B | 44.0% | 44.0% | $448.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SAIA // BETA 1.12
TMO // BETA 0.94